Detalhe da pesquisa
1.
Safety, Virology, Pharmacokinetics, and Clinical Experience of High-Dose Intravenous Sotrovimab for the Treatment of Mild to Moderate COVID-19: An Open-Label Clinical Trial.
Open Forum Infect Dis
; 10(7): ofad344, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37520411